Latest Posts

All Posts

Guest Blogger

Recent Posts

Advice on Career Paths and the Green Card Process for International Researchers and Entrepreneurs

Posted by Guest Blogger on Dec 20, 2017 9:33:58 AM

This post was contributed by guest bloggers Lauren Celano of Propel Careers and Rachel Casseus, Esq. Founder of Casseus Law.

Disclaimer: The contents of this post are intended to convey general information only and not to provide legal advice or opinions. The contents of this post should not be relied upon for legal advice in any particular circumstance or fact situation.  The information presented may not reflect the most current legal developments.  Further, this post may contain technical inaccuracies or typographical errors.  No action should be taken in reliance on the information contained in this post and we disclaim all liability in respect to actions taken or not taken based on any or all the contents of this post.  An attorney should be contacted for advice on specific legal issues. 

The permanent residence “green card” process is a necessary and often overlooked part of career development for foreign national researchers and entrepreneurs who are looking to continue their careers in the United States. There has been a growing shift away from employers sponsoring individuals for green cards because of the cost, long timeline and uncertainty associated with filing a permanent residence case with United States Citizenship and Immigration Services (USCIS). If it were up to us, we would give everyone with a Ph.D. a green card, but until we get elected to Congress, we are tasked with working with US immigration in its current state. As of September 2017, USCIS received 116,224 employment based green card applications and approved 91,023 during the first 3 quarters of 2017. As an international researcher and aspiring entrepreneur, you have many career options available to you including careers in academia, industry, non-profit, and government sectors.  Within these sectors, you could start your own company, work in a bench research career or a non-bench research career such as law, medical/technical writing, clinical, regulatory, product development, business development, consulting, policy, big data and the list goes on and on.

Read More >

Topics: Career

The Strength of Story Telling

Posted by Guest Blogger on Dec 19, 2017 9:00:17 AM

This post was contributed by guest blogger Jack Leeming Editor of Naturejobs, part of Nature magazine.

Humans are built to enjoy, remember, and listen to narratives — take advantage of that in your work

The part of my job I most enjoy is building and telling interesting stories — whether I’m working with a talented journalist to shine light on living as a scientist in Beijing, talking to people about taking beautiful photographs of their studies, reporting on amazing women in science, or asking someone how and why they left academia. Humans are designed to pay attention and enjoy anecdotal forms of information — identifying with a character, building emotional investment and following cause-and-effect relationships are all things almost all of us are programmed to appreciate and understand.

Read More >

Topics: Science Communication

pCXLE toolkit: Efficient episomal plasmid-based method to reprogram peripheral blood cells to iPSCs

Posted by Guest Blogger on Dec 14, 2017 9:08:09 AM

This post was contributed by Kusumika (Kushi) Mukherjee, a Postdoc at Massachussetts General Hospital.

A little over a decade back when Yamanaka and colleagues reported that it is possible to reprogram differentiated cells into induced pluripotent stem cells (iPSCs) by the addition of reprogramming (or “Yamanaka”) factors, they changed the landscape of regenerative medicine. Their work opened up vast possibilities for the clinical and therapeutic applications of iPSCs. The generation of human iPSCs (hiPSCs) now provides an opportunity to develop and use patient-specific somatic cells that are otherwise difficult to obtain. These can then be used to perform cell therapy and to model diseases in vitro.

Find stem cell plasmids at Addgene

Read More >

Topics: Plasmid Technology, Hot Plasmids, Stem Cells

ReFigure: Save Scientific Figures into Dashboards and Share Your Insights

Posted by Guest Blogger on Dec 13, 2017 10:20:23 AM

This post was contributed by guest blogger Girija Goyal, cofounder of ReFigure.

Reading and exploration including replications and experiments resulting in “negative data” often dominate the early years of a project. Dissemination of the knowledge gained during this period occurs infrequently and rarely makes it into the small selection of data found in full-length publications. As early career researchers, we wondered how we could make the insights gained during this time more visible and thereby have a positive impact on science.

ReFigure saves time, knowledge and makes your insights discoverable. Watch this quick video to learn how ReFigure works and continue reading for more details.

Read More >

Topics: Scientific Sharing

Adeno Associated Virus (AAV) for Cell and Gene Therapy

Posted by Guest Blogger on Nov 7, 2017 8:59:12 AM

This post was contributed by guest blogger Harshana S De Silva Feelixge.

Subscribe to Viral Vectors Blog Posts

Gene therapy technologies hold great promise for improving or potentially curing human diseases that were previously thought to be incurable. Rapid advances in next generation sequencing technologies have allowed scientists to quickly identify underlying genetic causes of some human conditions, opening up new avenues for therapeutics that treat disease at the molecular level. For instance, if a disease is caused by a mutation in a single gene, it can potentially be treated by correcting the mutation or replacing the gene. A notable example is the treatment of Severe Combined Immune Deficiency disease (SCID-XI), also known as bubble boy syndrome. This disease is caused by mutations in the common cytokine receptor gamma chain (c) and is characterized by a lack of immune cell development and function. To date, gene therapy has been used to treat 10 infants with this disease. To do so, their T-cells were grown in vitro, their mutations corrected, and the T-cells were transferred back into the infants. Almost all patients have achieved persistent immunological reconstitution with a normally functioning T cell repertoire (1).

Read More >

Topics: Viral Vectors

Blog Logo Vertical-01.png
Click here to subscribe to the Addgene Blog
 
Subscribe